chr9-134842386-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000093.5(COL5A1):c.*83C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.736 in 1,532,632 control chromosomes in the GnomAD database, including 417,355 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.76 ( 44058 hom., cov: 32)
Exomes 𝑓: 0.73 ( 373297 hom. )
Consequence
COL5A1
NM_000093.5 3_prime_UTR
NM_000093.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0550
Publications
43 publications found
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- arterial disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 9-134842386-C-T is Benign according to our data. Variant chr9-134842386-C-T is described in ClinVar as Benign. ClinVar VariationId is 365741.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.839 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL5A1 | NM_000093.5 | c.*83C>T | 3_prime_UTR_variant | Exon 66 of 66 | ENST00000371817.8 | NP_000084.3 | ||
| COL5A1 | NM_001278074.1 | c.*83C>T | 3_prime_UTR_variant | Exon 66 of 66 | NP_001265003.1 | |||
| LOC101448202 | NR_103451.2 | n.71-22177G>A | intron_variant | Intron 1 of 1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.757 AC: 115116AN: 152020Hom.: 44011 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
115116
AN:
152020
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.734 AC: 1013449AN: 1380494Hom.: 373297 Cov.: 21 AF XY: 0.735 AC XY: 505199AN XY: 687364 show subpopulations
GnomAD4 exome
AF:
AC:
1013449
AN:
1380494
Hom.:
Cov.:
21
AF XY:
AC XY:
505199
AN XY:
687364
show subpopulations
African (AFR)
AF:
AC:
27248
AN:
32004
American (AMR)
AF:
AC:
23443
AN:
39754
Ashkenazi Jewish (ASJ)
AF:
AC:
19361
AN:
25284
East Asian (EAS)
AF:
AC:
23707
AN:
37948
South Asian (SAS)
AF:
AC:
62048
AN:
82082
European-Finnish (FIN)
AF:
AC:
35306
AN:
46832
Middle Eastern (MID)
AF:
AC:
3473
AN:
4326
European-Non Finnish (NFE)
AF:
AC:
776124
AN:
1054714
Other (OTH)
AF:
AC:
42739
AN:
57550
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
13585
27170
40755
54340
67925
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
18918
37836
56754
75672
94590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.757 AC: 115215AN: 152138Hom.: 44058 Cov.: 32 AF XY: 0.754 AC XY: 56079AN XY: 74350 show subpopulations
GnomAD4 genome
AF:
AC:
115215
AN:
152138
Hom.:
Cov.:
32
AF XY:
AC XY:
56079
AN XY:
74350
show subpopulations
African (AFR)
AF:
AC:
35128
AN:
41518
American (AMR)
AF:
AC:
9879
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
2672
AN:
3468
East Asian (EAS)
AF:
AC:
3178
AN:
5136
South Asian (SAS)
AF:
AC:
3718
AN:
4818
European-Finnish (FIN)
AF:
AC:
8061
AN:
10606
Middle Eastern (MID)
AF:
AC:
239
AN:
294
European-Non Finnish (NFE)
AF:
AC:
50262
AN:
67982
Other (OTH)
AF:
AC:
1584
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1390
2780
4170
5560
6950
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
854
1708
2562
3416
4270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2468
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Ehlers-Danlos syndrome type 7A Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.